As AI pioneer Anthropic prepares to open its doors to public investors, the company is withholding one crucial detail from everyday shareholders: the identities of the individuals chosen to inherit its founders' immense voting power, and even the right to look at who is on the list. Hidden deep within the artificial intelligence giant's initial public offering filing is an intricate and highly unconventional succession framework relying on confidential rosters of handpicked successors.

Inside the Secret Founder-Designated Heir Lists

According to the Anthropic Founders, LLC agreement attached directly to the enterprise's S-1 filing, each founder holds the authority to nominate a prioritized roster of up to 10 potential heirs. These selections require formal endorsement from five out of the six remaining cofounders before officially locking in who will assume control of their votes.

While succession clauses remain standard practice among founder-led corporations—such as Facebook's IPO blueprint designating a successor chosen by Mark Zuckerberg—Anthropic's approach introduces three unprecedented deviations:

  • The compiled roster of heirs remains strictly confidential.
  • The list is prioritized, establishing a fixed and predetermined order of succession.
  • Although the board's governance committee can formally request that founders reevaluate their choices, it possesses no veto power over an approved list.

Separating Corporate Control From Economic Value

This ultimate founder authority operates through five distinct share classes introduced by Anthropic: A, E, F, N, and T. When the enterprise goes public, everyday retail investors will be cleared to purchase Class A shares. Meanwhile, Class F shares—the exact instruments tied to these succession directives—allocate 50.1% of general shareholder voting power exclusively to the founders. This mechanism is purposefully engineered to protect their governance authority even as they divest or gift their economic stakes, effectively cleaving corporate control away from underlying financial value. However, this voting majority does not grant the founders unilateral oversight of the board; that specific authority rests with the Long Term Benefit Trust, which was created to defend Anthropic's core public benefit mission.

Though the designated successors remain hidden from public view, the S-1 filing outlines strict qualification criteria. The initial eight candidates on every founder's roster must either be current or former personnel of Anthropic and its subsidiaries, or current or former workers and service providers at a 501(c)(3) tax-exempt entity, or an international or national institution whose core mission centers on research, education, or public benefit advocacy.

Candidates qualifying via Anthropic must have occupied technical, policy, compliance, or Anthropic Institute positions, or alternative roles cleared by the board and a majority of fellow LLC members. External candidates, conversely, are required to have operated at a senior leadership tier.

These eligibility parameters vanish completely for the ninth and tenth candidates on the list, where standard rules no longer apply, though they still demand supermajority authorization from the remaining members.

Defining Incapacitation and Multi-Billion Dollar Windfalls

Much like any legal structure designed to outlive its creators, the succession blueprint explicitly outlines the exact circumstances under which a voting council member is deemed incapacitated and stripped of their authority. The definition accounts for standard medical emergencies—such as an impairment expected to cause death within 12 months or halt substantial gainful activity for a comparable period—before expanding far beyond clinical scenarios into geopolitical hazards. It includes wrongful imprisonment, unlawful detention, captivity, or restraint anticipated to endure for 12 months or more that appears arbitrary or executed without due process of law.

This elaborate succession architecture yields an exceptionally lucrative outcome for Anthropic's leadership. Beyond preserving ironclad control over the organization, the founders stand to accumulate astronomical fortunes by offloading Class A shares to public markets.

Estimates indicate that the equity holdings belonging to the two most prominent cofounders—CEO Dario Amodei, 43, and his sister, Anthropic president and chairperson Daniela Amodei, 39—sit at roughly $13.6 billion and $13.7 billion, respectively. They stand as the sole cofounders publicly confirmed to have participated alongside other executives and staff in massive share liquidations totaling $4.7 billion in April 2026 and $157 million in June 2025. The exact volume of stock divested by the Amodeis during these tender offers remains undisclosed. Additional participants who unloaded shares include CFO Krishna Rao, who came on board in 2024, and Holden Karnofsky, the husband of Daniela Amodei who also acts as chairman of Anthropic's board.

Meanwhile, Anthropic's remaining cofounders—Head of Public Benefit Jack Clark, 38, and Chief Science Officer Jared Kaplan, 42—hold stakes valued at an estimated $13.7 billion each. Prior calculations based on a May private funding round suggested that each of the seven cofounders maintained 1.6% stakes valued around $15.5 billion. While official IPO pricing has not yet been finalized, market watchers report the company is targeting a staggering valuation bracket between $1.5 trillion and $2 trillion, a milestone that would easily push every cofounder's individual net worth past the $20 billion threshold.